Breaking News Instant updates and real-time market news.

KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

, LRCX

Lam Research

$96.17

1.34 (1.41%)

08:28
10/06/16
10/06
08:28
10/06/16
08:28

Cowen says to buy KLA-Tencor following merger agreement termination

Cowen analyst Timothy Arcuri said the KLA-Tencor (KLAC) merger with Lam Research (LRCX) was called off as expected. He said it was consistent with his assessment and believes Intel (INTC) was the culprit. The companies cited review of options amid recent ant-trust agency feedback. Arcuri said he continues to like Lam Research but prefers KLA-Tencor as he sees it as one of the only semi companies with roughly 30% upside. Arcuri maintained his Outperform rating and $80 price target on KLA-Tencor shares.

KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

LRCX

Lam Research

$96.17

1.34 (1.41%)

INTC

Intel

$37.99

0.45 (1.20%)

  • 06

    Oct

  • 19

    Oct

  • 18

    Nov

KLAC KLA-Tencor
$71.21

0.91 (1.29%)

10/06/16
RILY
10/06/16
UPGRADE
Target $86
RILY
Buy
KLA-Tencor upgraded to Buy from Neutral at B. Riley
B. Riley analyst Craig Ellis upgraded KLA-Tencor (KLAC) to Buy and raised his price target for the shares to $86 from $78 after the company discontinued its proposed merger with Lam Research (LRCX).
10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Lam Research outlook still positive after merger terminated, says RBC Capital
After Lam Research (LRCX) and KLA-Tencor (KLAC) announced that their merger had been terminated, RBC Capital analyst Amit Daryanani remains upbeat on Lam's outlook as a standalone entity. He expects the company to benefit from strong 3D-NAND spending in 2017, and he keeps a $105 price target and Outperform rating on the stock.
10/06/16
JPMS
10/06/16
NO CHANGE
JPMS
Overweight
JPMorgan recommends buying KLA-Tencor after merger termination
JPMorgan analyst Harlan Sur says that while the terminated merger is "disappointing for both parties," both KLA-Tencor (KLAC) and Lam Research (LRCX) are undervalued on a standalone basis. The analyst expects KLA-Tencor to be "aggressive buyers" of its own stock. He sees share upside to the $85-$90 range and keeps an Overweight rating on the name. Sur recommends buying the shares.
10/06/16
BREN
10/06/16
UPGRADE
BREN
Buy
KLA-Tencor upgraded to Buy from Hold at Berenberg
LRCX Lam Research
$96.17

1.34 (1.41%)

10/05/16
RBCM
10/05/16
NO CHANGE
RBCM
Micron report reads positively for Applied Materials, Lam, says RBC Capital
Following Micron's (MU) quarterly report and guidance, RBC Capital Amit Daryanani said he sees positive read-through from the report for Applied Materials (AMAT), Lam Research (LRCX), ASML (ASML), Western Digital (WDC) and Intel (INTC). Micron management expects capex spending of $4.8B-$5.2B for FY17, noted Daryanani, who believes continued 3D NAND spending will benefit Applied and Lam the most.
INTC Intel
$37.99

0.45 (1.20%)

09/20/16
BMUR
09/20/16
NO CHANGE
Target $40
BMUR
Buy
Intel guidance raise not a surprise, says Brean Capital
Brean Capital analyst Mike Burton noted Intel raised its guidance last week citing the replenishment of the PC supply chain inventory and improving PC demand. The analyst said he was not surprised by the announcement given anecdotal positive data from many of the suppliers in the sector. Burton believes Intel remains well positioned and so reiterated his Buy rating and increased his price target to $40 from $38 on Intel shares.
09/20/16
ADAM
09/20/16
NO CHANGE
Target $44
ADAM
Buy
Intel price target raised to $44 from $40 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Intel to $44 from $40 following the company's positive pre-announcement. The analyst increased his estimates as well and said with its attractive dividend yield and valuation, Intel should be a core holding for investors. Ramsay reiterated his Buy rating on Intel shares.
09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NOV

National Oilwell

$37.91

-1.01 (-2.60%)

06:40
01/19/18
01/19
06:40
01/19/18
06:40
Hot Stocks
National Oilwell sees Q4 results at or above prior expectations »

National Oilwell Varco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

UDN

PowerShares DB US Dollar Index Down

$22.78

0.03 (0.13%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Hot Stocks
Synchrony reports Q4 net interest margin 16.24% compared to 16.26% last year »

Return on assets was 1.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PB

Prosperity Bancshares

$74.26

-0.2 (-0.27%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Prosperity Bancshares announces stock repurchase program »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

, BIIB

Biogen

$344.44

-0.43 (-0.12%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Periodicals
Biogen among companies weighing bids for Acorda, Bloomberg reports »

Biogen (BIIB) and…

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Mar

SYF

Synchrony

$37.31

-0.75 (-1.97%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Synchrony reports estimated Common Equity Tier 1 ratio 16% »

The estimated Common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MRK

Merck

$61.13

-0.9 (-1.45%)

, AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Merck, AstraZeneca: LYNPARZA receives approval in Japan »

AstraZeneca (AZN) and…

MRK

Merck

$61.13

-0.9 (-1.45%)

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

GWR

Genesee & Wyoming

$81.57

0.18 (0.22%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Genesee & Wyoming reports December traffic 255,199 carloads, down 5,7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Hot Stocks
Synchrony reports Q4 net interest income up 8% to $3.9B »

Loan receivables grew $6…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FHN

First Horizon

$20.21

-0.09 (-0.44%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Earnings
First Horizon reports Q4 EPS (20c) may not compare with consensus 30c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Periodicals
AstraZeneca sees big productivity jump amid fewer drug projects, Reuters reports »

AstraZeneca has seen an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

  • 08

    Mar

  • 23

    Apr

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Breaking Earnings news story on Wipro »

Wipro sees Q4 IT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Wipro reports Q3 revenue $2.1B, consensus $2.1B »

IT Services Segment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Hot Stocks
Breaking Hot Stocks news story on Citizens Financial »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

JAPAF

Japan Tobacco

$32.91

-0.29 (-0.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Upgrade
Japan Tobacco rating change  »

Japan Tobacco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:32
01/19/18
01/19
06:32
01/19/18
06:32
Hot Stocks
Citizens Financial raises quarterly dividend 22% to 22c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

PM

Philip Morris

$105.07

-0.72 (-0.68%)

, MO

Altria Group

$70.03

-0.12 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Upgrade
Philip Morris, Altria Group, British American Tobacco rating change  »

Philip Morris upgraded to…

PM

Philip Morris

$105.07

-0.72 (-0.68%)

MO

Altria Group

$70.03

-0.12 (-0.17%)

BTI

British American Tobacco

$68.56

-0.82 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Earnings
Citizens Financial reports Q4 EPS $1.35 with items, consensus 67c »

Reports Q4 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Earnings
Breaking Earnings news story on Synchrony »

Synchrony reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MO

Altria Group

$70.03

-0.12 (-0.17%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Upgrade
Altria Group rating change  »

Altria Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

JBHT

J.B. Hunt

$121.45

0.8 (0.66%)

06:28
01/19/18
01/19
06:28
01/19/18
06:28
Recommendations
J.B. Hunt analyst commentary  »

J.B. Hunt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$27.68

0.175 (0.64%)

06:25
01/19/18
01/19
06:25
01/19/18
06:25
Periodicals
Emirates A380 order enables Airbus to maintain minimum production, Reuters says »

Emirates' recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$76.30

-0.28 (-0.37%)

, DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

06:23
01/19/18
01/19
06:23
01/19/18
06:23
Periodicals
United to offer premium economy on international flights, CNBC reports »

United Airlines (UAL) is…

UAL

United Continental

$76.30

-0.28 (-0.37%)

DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

AAL

American Airlines

$58.34

0.18 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 21

    Mar

LQ

La Quinta

$20.18

0.73 (3.75%)

, WYN

Wyndham

$122.73

5.6 (4.78%)

06:22
01/19/18
01/19
06:22
01/19/18
06:22
Recommendations
La Quinta, Wyndham analyst commentary  »

La Quinta price target…

LQ

La Quinta

$20.18

0.73 (3.75%)

WYN

Wyndham

$122.73

5.6 (4.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

GE

General Electric

$16.77

-0.58 (-3.34%)

06:19
01/19/18
01/19
06:19
01/19/18
06:19
Recommendations
General Electric analyst commentary  »

GE may be forced to raise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.